Cardiopulmonary Disease Clinical Trial
Official title:
Clinical Validation Study for Noninvasive Cardiopulmonary Management Device
Verified date | October 2023 |
Source | Analog Device, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is designed to be a clinical validation study to ready the CPM System for FDA 510(k) submission. This study will be conducted as a prospective non-randomized. The study is non-significant risk since the CPM Device is noninterventional and noninvasive. The study is primarily designed to validate the accuracy of the respiration rate and the changes in relative tidal volume. All participants will be fitted with both the CPM Device as well as reference devices (capnography and ECG). Participants will be randomized between 4 procedures (A-D) which will determine the order of 10 exercises. Each exercise has about 2 minutes of device recording and two minutes of rest. Each exercise contains two positions: sitting up for one minute and lying down for one minute. For some exercises, the participant will be instructed to breathe at a certain rate (assisted by a metronome). For other exercises, the participants will breathe at a normal rate but change how deep the are breathing. For the last, all capnography reference devices will be removed, and an ECG reference device will be placed. After exercise 18, the participant will have all devices removed and the study visit will terminate. The participant will receive a safety follow-up call about 1 week after their visit.
Status | Active, not recruiting |
Enrollment | 40 |
Est. completion date | November 1, 2023 |
Est. primary completion date | August 4, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults over the age of 18 and who are willing and able to give informed consent - Willing and able to participate in all activities related to this study, including trimming chest hair and wearing a reference device and the CPM wearable device - Volunteers of any race, any gender - Range of physiques - Healthy Exclusion Criteria: - Injury or skin disturbance in the area of the test device - Allergies or sensitivities to silicone/acrylic-based adhesive - Pregnant - Currently smokes cigarettes - Has known respiratory conditions that might prevent them from following the study procedure such as: - Flu - Pneumonia/bronchitis - Shortness of breath/respiratory distress - Respiratory or lung surgery - Emphysema, COPD, lung disease - Has self-reported heart or cardiovascular conditions such as chest pain, AFib, CHF, cardiomyopathy, or other conditions that could interfere with cardiopulmonary function - Has other self-reported health conditions that could interfere with the breathing patterns and exercises detailed in the protocol (including wearing a capnography mask) |
Country | Name | City | State |
---|---|---|---|
United States | Clayton Sleep Institute | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
Analog Device, Inc. | Clayton Sleep Insititute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Accuracy of CPM System calculated RR versus reference device | Proportion of the errors within ± 2bpm | Baseline | |
Primary | Accuracy of the changes in the rTV calculated by CPM System compared to reference TV, if data is available. | Root Mean Squared (RMS) of residual relative error after linear fitting | Baseline | |
Primary | Accuracy of the changes in the rTV calculated by CPM System compared to reference TV, if data is available. | Correlation coefficient between reference device's TV and test device's rTV within subjects | Baseline | |
Secondary | Accuracy of CPM system calculated RR compared to reference device | Confirm that respiration rates of test device and reference device align | Baseline | |
Secondary | Skin temperature confirmation. | Confirm that ECG characteristics align with those from reference device | Baseline | |
Secondary | ECG confirmation. | Confirm that ECG readings align with those from reference device | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04844307 -
Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups
|
N/A | |
Recruiting |
NCT05733767 -
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
|
Phase 2 | |
Completed |
NCT01466218 -
World Trade Center (WTC) CHEST
|
N/A | |
Completed |
NCT04865640 -
Clinical Validation Study for Noninvasive Cardiopulmonary Management Device
|
||
Not yet recruiting |
NCT05079724 -
Acute Kidney Injury After Cardiac Surgery
|
||
Terminated |
NCT03501927 -
Focused Cardiac Ultrasound in Surgery
|
N/A | |
Recruiting |
NCT04863677 -
The Effect of HIIT, MICT in Patients With Myocardial Infarction
|
N/A | |
Completed |
NCT05776264 -
Exercise Strategies to Motivate and Relieve Stress
|
N/A | |
Completed |
NCT02246101 -
World Trade Center (WTC) RENAL
|
N/A | |
Completed |
NCT03911856 -
Unmasking Right Ventricular and Pulmonary Derangements With Exercise and Oxygen in Early Stage Cardiopulmonary Diseases
|
N/A | |
Recruiting |
NCT03368755 -
IUGR, Respiratory Muscle Function, and Exercise Capacity in Childhood
|
N/A | |
Completed |
NCT01639235 -
Effects of Secondhand Smoke on Flight Attendant Health
|
||
Completed |
NCT02671669 -
Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology
|
N/A | |
Not yet recruiting |
NCT04939220 -
SGA for TEE: Safe Alternative to Deep Sedation for Patients With High-risk Cardiopulmonary Disease.
|
N/A | |
Completed |
NCT03319056 -
Indoor Air and Children Health Study
|
N/A | |
Recruiting |
NCT04859894 -
Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation
|